Star Combo Pharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	3.59	2.16	2.99	4.39	7.27
Short-Term Investments	14.52	5.2	6.5	6	10.05
Cash & Short-Term Investments	18.11	7.36	9.49	10.39	17.32
Cash Growth	146.14%	-22.44%	-8.71%	-40.01%	-34.88%
Accounts Receivable	2.03	4.19	3.79	1.98	2
Other Receivables	0.35	0.29	0.28	0.76	0.57
Receivables	2.38	4.48	4.07	2.75	2.57
Inventory	4.97	6.34	4.2	5.37	4.5
Other Current Assets	0.32	0.17	0.34	0.57	2.03
Total Current Assets	25.79	18.35	18.1	19.08	26.43
Property, Plant & Equipment	21.6	23.1	22.72	22.74	13.48
Other Intangible Assets	0.67	0.68	0.69	0.7	2.51
Long-Term Deferred Tax Assets	0.39	0.68	0.71	0.92	0.9
Other Long-Term Assets	-	-0	-	-	-
Total Assets	48.45	42.82	42.23	43.44	43.32
Accounts Payable	3.95	2.82	2.44	2.34	2.12
Current Portion of Long-Term Debt	0.02	0.01	0.04	0.04	0.03
Current Portion of Leases	0.17	0.15	0.13	0.13	0.14
Current Income Taxes Payable	-	0.23	-	-	-
Other Current Liabilities	1.72	1.67	1.73	1.5	1.25
Total Current Liabilities	5.86	4.87	4.33	4.01	3.55
Long-Term Debt	0.04	-	0.01	0.08	0.12
Long-Term Leases	3.71	3.87	4.02	3.87	3.01
Long-Term Deferred Tax Liabilities	0.54	0.54	0.54	0.02	0.42
Other Long-Term Liabilities	0.05	0.03	0.07	0.06	0.04
Total Liabilities	10.19	9.3	8.97	8.04	7.13
Common Stock	67.29	67.29	67.29	67.22	67.32
Retained Earnings	-5.32	-10.08	-10.31	-7.06	-6.51
Comprehensive Income & Other	-23.89	-23.89	-23.89	-24.75	-24.62
Total Common Equity	38.08	33.32	33.09	35.41	36.19
Minority Interest	0.19	0.19	0.17	-	-
Shareholders' Equity	38.26	33.51	33.26	35.41	36.19
Total Liabilities & Equity	48.45	42.82	42.23	43.44	43.32
Total Debt	3.93	4.03	4.19	4.12	3.3
Net Cash (Debt)	14.18	3.33	5.3	6.27	14.03
Net Cash Growth	325.81%	-37.12%	-15.56%	-55.29%	-33.16%
Net Cash Per Share	0.10	0.02	0.04	0.05	0.10
Filing Date Shares Outstanding	135.08	135.08	135.08	134.58	134.79
Total Common Shares Outstanding	135.08	135.08	135.08	134.58	134.79
Working Capital	19.93	13.48	13.77	15.07	22.88
Book Value Per Share	0.28	0.25	0.24	0.26	0.27
Tangible Book Value	37.41	32.65	32.4	34.71	33.68
Tangible Book Value Per Share	0.28	0.24	0.24	0.26	0.25
Land	6.07	6.07	6.05	3.91	3.91
Machinery	6.98	6.8	4.93	3.09	2.98
Construction In Progress	0.29	0.8	8.28	13.08	4.46
Leasehold Improvements	9.52	9.3	2.28	1.01	1.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.